BCL2 and CLIP2 expression association analysis across 3 pediatric patients with AML treated with ADE-containing regimens. High expression of BCL2 and CLIP2 showed unfavorable outcomes in at least one of the end points (EFS, OS, and MRD1) in AML02, TARGET.0531, and TARGET.1031. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001.